RNFL thickness results for healthy eyes, eyes suffering from primary open angle glaucoma (POAG), and from capsular glaucoma (CG)
| RNFL thickness (μm) and superior to inferior thickness ratio (mean (SD)) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Before pilocarpine treatment | After pilocarpine treatment | ||||||||
| (1) Control (n=35) | (2) POAG (n=30) | (3) CG (n=18) | p Value | (4) POAG (n=23) | (5) CG (n=14) | p Value | |||
| Total circumference | 64.71 (8.11) | 57.88 (8.59) | 57.25 (9.22) | p1–2=0.003 | 56.60 (6.79) | 56.04 (9.55) | p+ 2–4=0.807 | ||
| p1–3=0.03 | p+ 3–5=0.699 | ||||||||
| p2–3=0.81 | |||||||||
| Superior quadrant | 77.52 (11.53) | 63.01 (10.84) | 61.02 (12.05) | p1–2=0.0002 | 61.46 (10.05) | 60.27 (12.31) | p+ 2–4=0.980 | ||
| p1–3=0.003 | p+ 3–5=0.803 | ||||||||
| p2–3=0.57 | |||||||||
| Temporal quadrant | 47.42 (11.00) | 47.58 (10.68) | 47.00 (7.44) | p*=0.98 | 49.16 (8.54) | 46.23 (9.30) | p+ 2–4=0.354 | ||
| p+ 3–5=0.848 | |||||||||
| Inferior quadrant | 77.26 (12.79) | 65.27 (13.51) | 66.98 (13.52) | p1–2=0.004 | 62.23 (11.03) | 64.41 (13.54) | p+ 2–4=0.482 | ||
| p1–3=0.02 | p+ 3–5=0.097 | ||||||||
| p2–3=0.67 | |||||||||
| Nasal quadrant | 54.85 (7.62) | 54.29 (7.69) | 53.03 (9.14) | p*=0.75 | 53.03 (6.88) | 52.06 (8.43) | p+ 2–4=0.249 | ||
| p+ 3–5=0.924 | |||||||||
| Superior to inferior thickness ratio |
1.01 (0.14) |
0.98 (0.15) |
0.92 (0.11) |
p*=0.073 |
1.00 (0.15) |
0.94 (0.11) |
p+ 2–4=0.623 | ||
| p+ 3–5=0.080 | |||||||||
p* = ANOVA, p = Duncan test when p*<0.05, p+=paired t test.